www.skpgroup.com August 2007
Your eye to India-centric and International updates
In the News

Genome Valley gets US certification

Genome Valley, India’s first biotech cluster, has been granted the certification mark (intellectual property rights) by the United States Patent and Trademark Office (USPTO).

The Andhra Pradesh technology development and promotion centre (APTDC) with the support of the state government had been working on the registration for the project since 2003.
It was also granted a community trademark (intellectual property rights) by the European Union in 2005.

Located near the outskirts of Hyderabad, Genome Valley provides world-class infrastructure to over 100 biotech companies. Spread over 600 sq km it is being promoted as a natural cluster for biotech research, training, collaboration and manufacturing facilities.

The US registration will greatly enhance the credibility of Genome Valley in the US and Europe boosting foreign investment in the cluster. The Andhra industries and commerce department is the authorised user of the certification mark.

Certification marks are a form of intellectual property (IP) right, conferred for compliance with definite standards.

Print this ArticleTop
 
In the News
London Chamber to set up 250 learning centres in Gujarat
Genome Valley gets US certification

Interesting Reads
Global realty funds to boost Indian real estate scenario
Gujarat the emerging biotech hub
Reverse trend in India’s BPO industry
Auto majors eye 1 mn car exports by 2010

Quick Links
India tops consumer confidence index
FDI in telecom raised to 74%
Indian companies can now invest up to 300 % abroad / changes in inbound investment
International players to invest in locomotive manufacturing in India

India Inc
- Investment briefs
Japanese company to fund Punjab civil project
ICICI Bank joins US$ 24.75 bn club
DP World's arm to start work in Kerala by Dec
Bangalore is Lenovo's marketing hub
Rel Comm buys US firm Yipes at US$ 300 mn
Toyota to augment India capacity to 6,00,000 by 2015
NPIL gets nod to test cancer drug in US

Hope you enjoyed this edition of ‘eye to I’
Please feel free to mail us -
-
any suggestions / comments that would help us enhance this e-supplement
-
requests for further information or advice
-
a request to meet
© 2007 SKP Group Email to a Friend | Unsubscribe | Feedback | Disclaimer